Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
TMCI
$4.79
+6.21%
TMCI · Treace Medical Concepts, Inc.
$4.79
+0.28 (+6.21%)
At close · Aug 14
Market Cap
$311.52M
Shares
65.03M
All earnings calls
Earnings call · FY2026 Q2
Treace Medical Concepts, Inc. Q2 FY2026 Earnings Call
Treace Medical Concepts, Inc. Q2 FY2026 Earnings Call
Forward guidance
2 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$45.38M
-4.2% YoY
Diluted EPS
-$0.24
Gross margin
78.5%
-1.2 pp YoY
Net income
-$15.87M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 7, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenue
full-year 2026
|
$204M – $212M | — | |
|
Adjusted EBITDA
full year 2026
|
$-5M – $-3M | Non-GAAP |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 7, 2026 · complete as-filed document